0001179110-22-000282.txt : 20220105
0001179110-22-000282.hdr.sgml : 20220105
20220105183934
ACCESSION NUMBER: 0001179110-22-000282
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220103
FILED AS OF DATE: 20220105
DATE AS OF CHANGE: 20220105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schlanger David J
CENTRAL INDEX KEY: 0001576145
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39100
FILM NUMBER: 22512929
MAIL ADDRESS:
STREET 1: C/O PROGYNY, INC.
STREET 2: 1359 BROADWAY, 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Progyny, Inc.
CENTRAL INDEX KEY: 0001551306
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
IRS NUMBER: 272220139
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 212-888-3124
MAIL ADDRESS:
STREET 1: 1359 BROADWAY
STREET 2: 2ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn, Inc.
DATE OF NAME CHANGE: 20150318
FORMER COMPANY:
FORMER CONFORMED NAME: Auxogyn Inc
DATE OF NAME CHANGE: 20120601
4
1
edgar.xml
FORM 4 -
X0306
4
2022-01-03
0
0001551306
Progyny, Inc.
PGNY
0001576145
Schlanger David J
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL
NEW YORK
NY
10018
1
1
0
0
Executive Chairman
Common Stock
2022-01-03
4
M
0
50000
0.91
A
134000
D
Common Stock
2022-01-03
4
S
0
50000
51.17
D
84000
D
Common Stock
2022-01-04
4
M
0
704
0.91
A
84704
D
Common Stock
2022-01-04
4
S
0
704
51.27
D
84000
D
Employee Stock Option (Right to Buy)
0.91
2022-01-03
4
M
0
50000
0
D
2027-08-03
Common Stock
50000
2184384
D
Employee Stock Option (Right to Buy)
0.91
2022-01-04
4
M
0
704
0
D
2027-08-03
Common Stock
704
2183680
D
Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.93 to $51, inclusive.
The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.08 to $51.76, inclusive.
One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date.
/s/ Jennifer Bealer, Attorney-in-Fact
2022-01-05